Suchergebnisse - "Tice, Jeffrey A"

PubPharm (184)

41

Long-term Survival and Value of Chimeric Antigen Receptor T-Cell Therapy for Pediatric Patients With Relapsed or Refractory Leukemia

enthalten in: JAMA pediatrics | 2018

von Whittington, M. | McQueen, R. | Ollendorf, D. | +5

CommentIn: JAMA Pediatr. 2018 Dec 1;172(12):1123-1124. - PMID 30304346

42

Disease-Modifying Therapies for Relapsing–Remitting and Primary Progressive Multiple Sclerosis: A Cost-Utility Analysis

enthalten in: CNS drugs | 2018

von Zimmermann, M. | Brouwer, E. | Tice, J. | +6

43

Disease-Modifying Therapies for Relapsing–Remitting and Primary Progressive Multiple Sclerosis: A Cost-Utility Analysis

enthalten in: CNS drugs | 2018

von Zimmermann, M. | Brouwer, E. | Tice, J. | +6

44

Disease-Modifying Therapies for Relapsing–Remitting and Primary Progressive Multiple Sclerosis: A Cost-Utility Analysis

enthalten in: CNS drugs | 2018

von Zimmermann, M. | Brouwer, E. | Tice, J. | +6

45

Family History and Breast Cancer Risk Among Older Women in the Breast Cancer Surveillance Consortium Cohort

enthalten in: JAMA internal medicine | 2018

von Braithwaite, D. | Miglioretti, D. | Zhu, W. | +11

46

Joint relative risks for estrogen receptor-positive breast cancer from a clinical model, polygenic risk score, and sex hormones

enthalten in: Breast cancer research and treatment | 2017

von Shieh, Y. | Hu, D. | Ma, L. | +7

47

Updated Cost-effectiveness Analysis of PCSK9 Inhibitors Based on the Results of the FOURIER Trial

enthalten in: JAMA | 2017

von Kazi, D. | Penko, J. | Coxson, P. | +4

CommentIn: JAMA. 2017 Aug 22;318(8):711-712. - PMID 28829851

48

Joint relative risks for estrogen receptor-positive breast cancer from a clinical model, polygenic risk score, and sex hormones

enthalten in: Breast cancer research and treatment | 2017

von Shieh, Y. | Hu, D. | Ma, L. | +7

49

Joint relative risks for estrogen receptor-positive breast cancer from a clinical model, polygenic risk score, and sex hormones

enthalten in: Breast cancer research and treatment | 2017

von Shieh, Y. | Hu, D. | Ma, L. | +7

50

Joint relative risks for estrogen receptor-positive breast cancer from a clinical model, polygenic risk score, and sex hormones

enthalten in: Breast cancer research and treatment | 2017

von Shieh, Y. | Hu, D. | Ma, L. | +7